Amit Hazan

Stock Analyst at Goldman Sachs

(2.13)
# 2,824
Out of 4,944 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return

Stocks Rated by Amit Hazan

Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $87.36
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13$2.5
Current: $7.53
Upside: -66.80%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22$19
Current: $2.38
Upside: +698.32%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9$8
Current: $15.72
Upside: -49.11%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73$63
Current: $53.06
Upside: +18.73%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319$272
Current: $195.96
Upside: +38.80%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19$17
Current: $14.17
Upside: +19.97%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510$435
Current: $13.21
Upside: +3,192.96%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39$44
Current: $40.38
Upside: +8.96%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97$73
Current: $77.68
Upside: -6.02%
Maintains: Sell
Price Target: $60$53
Current: $24.11
Upside: +119.83%
Initiates: Buy
Price Target: $57
Current: $29.59
Upside: +92.63%
Maintains: Neutral
Price Target: $11$9.5
Current: $15.80
Upside: -39.87%
Maintains: Sell
Price Target: $111$104
Current: $129.40
Upside: -19.63%
Maintains: Neutral
Price Target: $80$60
Current: $13.57
Upside: +342.15%
Maintains: Neutral
Price Target: $129$115
Current: $92.91
Upside: +23.78%
Downgrades: Sell
Price Target: $248$150
Current: $378.95
Upside: -60.42%
Initiates: Neutral
Price Target: $46
Current: $102.50
Upside: -55.12%
Initiates: Buy
Price Target: $242
Current: $482.35
Upside: -49.90%
Initiates: Buy
Price Target: $177
Current: $103.22
Upside: +71.48%
Maintains: Neutral
Price Target: $139$147
Current: $174.42
Upside: -15.72%
Upgrades: Neutral
Price Target: $3.5$3.9
Current: $1.49
Upside: +161.74%